CommentaryCOVID-19 convalescent plasma therapy through the lens of the third year of the pandemic
Keywords
Convalescent plasma
COVID-19 convalescent plasma
COVID-19 pandemic
COVID-19 symptom duration
High titer
Immunosuppressed patients
SARS-CoV-2 antibodies
Serum therapy
Cited by (0)
© 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.